EP0949946A4 - Traitement de liquides biologiques - Google Patents
Traitement de liquides biologiquesInfo
- Publication number
- EP0949946A4 EP0949946A4 EP97954595A EP97954595A EP0949946A4 EP 0949946 A4 EP0949946 A4 EP 0949946A4 EP 97954595 A EP97954595 A EP 97954595A EP 97954595 A EP97954595 A EP 97954595A EP 0949946 A4 EP0949946 A4 EP 0949946A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- biological fluid
- obtaining
- leukocyte
- container
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000013060 biological fluid Substances 0.000 title claims abstract description 168
- 238000012545 processing Methods 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 31
- 230000012953 feeding on blood of other organism Effects 0.000 claims abstract description 16
- 210000000265 leukocyte Anatomy 0.000 claims description 63
- 210000004369 blood Anatomy 0.000 claims description 40
- 239000008280 blood Substances 0.000 claims description 39
- 239000003634 thrombocyte concentrate Substances 0.000 claims description 33
- 210000001772 blood platelet Anatomy 0.000 claims description 24
- 210000003743 erythrocyte Anatomy 0.000 claims description 22
- 239000006228 supernatant Substances 0.000 claims description 19
- 239000012530 fluid Substances 0.000 claims description 17
- 238000004891 communication Methods 0.000 claims description 9
- KRADHMIOFJQKEZ-UHFFFAOYSA-N Tri-2-ethylhexyl trimellitate Chemical compound CCCCC(CC)COC(=O)C1=CC=C(C(=O)OCC(CC)CCCC)C(C(=O)OCC(CC)CCCC)=C1 KRADHMIOFJQKEZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000013049 sediment Substances 0.000 claims description 8
- 238000010241 blood sampling Methods 0.000 claims description 5
- 230000000149 penetrating effect Effects 0.000 claims description 5
- 239000003146 anticoagulant agent Substances 0.000 claims description 3
- 229940127219 anticoagulant drug Drugs 0.000 claims description 3
- 239000004014 plasticizer Substances 0.000 claims description 3
- 239000012503 blood component Substances 0.000 description 28
- 239000000306 component Substances 0.000 description 24
- 210000004623 platelet-rich plasma Anatomy 0.000 description 23
- 241000894006 Bacteria Species 0.000 description 22
- 238000011176 pooling Methods 0.000 description 22
- 238000012546 transfer Methods 0.000 description 19
- 239000000463 material Substances 0.000 description 17
- 238000011109 contamination Methods 0.000 description 13
- 210000002381 plasma Anatomy 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 238000003860 storage Methods 0.000 description 10
- JNXDCMUUZNIWPQ-UHFFFAOYSA-N trioctyl benzene-1,2,4-tricarboxylate Chemical compound CCCCCCCCOC(=O)C1=CC=C(C(=O)OCCCCCCCC)C(C(=O)OCCCCCCCC)=C1 JNXDCMUUZNIWPQ-UHFFFAOYSA-N 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 8
- 239000010836 blood and blood product Substances 0.000 description 8
- 229940125691 blood product Drugs 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 239000003570 air Substances 0.000 description 6
- 230000002411 adverse Effects 0.000 description 5
- 239000004800 polyvinyl chloride Substances 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 230000003385 bacteriostatic effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 3
- 230000000779 depleting effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000003032 molecular docking Methods 0.000 description 3
- BJQHLKABXJIVAM-BGYRXZFFSA-N 1-o-[(2r)-2-ethylhexyl] 2-o-[(2s)-2-ethylhexyl] benzene-1,2-dicarboxylate Chemical compound CCCC[C@H](CC)COC(=O)C1=CC=CC=C1C(=O)OC[C@H](CC)CCCC BJQHLKABXJIVAM-BGYRXZFFSA-N 0.000 description 2
- 229920012485 Plasticized Polyvinyl chloride Polymers 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- -1 e.g. Substances 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000013022 venting Methods 0.000 description 2
- 206010060935 Alloimmunisation Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 208000009329 Graft vs Host Disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 210000001754 blood buffy coat Anatomy 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 208000024908 graft versus host disease Diseases 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
- A61M1/0218—Multiple bag systems for separating or storing blood components with filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D21/00—Separation of suspended solid particles from liquids by sedimentation
- B01D21/26—Separation of sediment aided by centrifugal force or centripetal force
- B01D21/262—Separation of sediment aided by centrifugal force or centripetal force by using a centrifuge
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0439—White blood cells; Leucocytes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2221/00—Applications of separation devices
- B01D2221/10—Separation devices for use in medical, pharmaceutical or laboratory applications, e.g. separating amalgam from dental treatment residues
Definitions
- stored and/or non-stored components typically include undesirable material such as bacteria and/or leukocytes.
- Bacteria can contaminate the blood or blood component during blood collection and/or storage.
- One source of bacterial contamination may be the blood donor's skin, which may contain one or more varieties of bacteria, e.g., gram positive bacteria such as Staphylococcus epidermidis. and S ⁇ aureus, and/or gram negative bacteria. Since swabbing the donor's skin (e.g. , with alcohol) prior to venipuncture may be inadequate to assure sterility, the bacteria may pass into the blood collection container, and the bacteria may reproduce while the blood or blood component is stored. Moreover, since some phlebotomy needles may cut a disc of skin when the phlebotomy needle is inserted into the donor, the bacteria-containing skin plug can pass with the blood into the blood collection container, and the bacteria can reproduce during storage.
- Figure 4B illustrates another embodiment of a biological fluid pooling system that can be used in accordance with the invention.
- the illustrated system includes a plurality of containers 12, each suitable for holding a biological fluid such as buffy coat, in fluid communication via conduits 160 with a first receiving container 118a for pooled buffy coat.
- the illustrated system in Figure 4B also includes a filter assembly 26, such as a leukocyte depletion assembly, interposed between the first receiving container 118a and a second receiving container 118a.
- the system also includes an additional container 20, e.g., for holding an additive or wash solution.
- pooled biological fluid is then recovered in the receiving or transfer container 118a and, in accordance with the invention, the introduction of air or gas into the receiving container can be minimized, so the biological fluid is recovered without collecting excess air.
- gas may be introduced behind the biological fluid retained in the system. Using the illustrative system illustrated in Figure 3 for reference, the gas that was initially introduced into the containers 18a through either the gas inlet 80 or the gas outlet 82 will follow the biological fluid as it flows through the conduits. This increases the recovery of the biological fluid, since the gas following the biological fluid "chases" the fluid from the conduits.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3414596P | 1996-12-24 | 1996-12-24 | |
| PCT/US1997/023558 WO1998028057A1 (fr) | 1996-12-24 | 1997-12-19 | Traitement de liquides biologiques |
| US34145P | 2008-03-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0949946A1 EP0949946A1 (fr) | 1999-10-20 |
| EP0949946A4 true EP0949946A4 (fr) | 2001-02-14 |
Family
ID=21874592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP97954595A Withdrawn EP0949946A4 (fr) | 1996-12-24 | 1997-12-19 | Traitement de liquides biologiques |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0949946A4 (fr) |
| JP (1) | JP2001507353A (fr) |
| AU (1) | AU736156B2 (fr) |
| CA (1) | CA2271440A1 (fr) |
| WO (1) | WO1998028057A1 (fr) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6592613B1 (en) | 1998-01-16 | 2003-07-15 | Terumo Kabushiki Kaisha | Blood collecting apparatus and blood collecting method using blood collecting apparatus |
| US7445756B2 (en) | 1999-06-03 | 2008-11-04 | Fenwal, Inc. | Fluid processing sets and organizers for the same |
| US7025877B1 (en) | 1999-06-03 | 2006-04-11 | Baxter International Inc. | Processing set for processing and treating a biological fluid |
| US6387086B2 (en) | 1999-07-29 | 2002-05-14 | Baxter International Inc. | Blood processing set including an integrated blood sampling system |
| AU6498600A (en) | 1999-07-29 | 2001-02-19 | Baxter International Inc. | Sampling tube holder for blood sampling system |
| US7435231B2 (en) | 1999-07-29 | 2008-10-14 | Fenwal, Inc. | Biological sample device receiver |
| EP1224258A2 (fr) * | 1999-10-29 | 2002-07-24 | Pall Corporation | Traitement de fluide biologique |
| JP2002173433A (ja) * | 2000-12-04 | 2002-06-21 | Terumo Corp | 白血球除去血液製剤の調製方法および血液セット |
| US7264608B2 (en) | 2001-12-05 | 2007-09-04 | Fenwal, Inc. | Manual processing systems and methods for providing blood components conditioned for pathogen inactivation |
| JP4837893B2 (ja) | 2001-12-10 | 2011-12-14 | カリディアンビーシーティー、インコーポレーテッド | 赤血球を白血球減少させる方法および装置 |
| US20040009542A1 (en) * | 2002-05-03 | 2004-01-15 | Gambro, Inc. | Apparatus and method for detecting bacteria in blood products |
| ITRM20030467A1 (it) * | 2003-10-10 | 2005-04-11 | Advance Holdings Ltd | Contenitore monouso per la centrifugazione ed il trattamento di un materiale biologico fluido. |
| PT2430977T (pt) * | 2009-05-14 | 2020-03-26 | Biotechnology Inst I Mas D Sl | Método para a preparação de pelo menos um composto do sangue, e dispositivo de amostragem para utilização na realização do referido método |
| US8535241B2 (en) | 2011-10-13 | 2013-09-17 | Magnolia Medical Technologies, Inc. | Fluid diversion mechanism for bodily-fluid sampling |
| US9060724B2 (en) | 2012-05-30 | 2015-06-23 | Magnolia Medical Technologies, Inc. | Fluid diversion mechanism for bodily-fluid sampling |
| US9022951B2 (en) | 2012-05-30 | 2015-05-05 | Magnolia Medical Technologies, Inc. | Fluid diversion mechanism for bodily-fluid sampling |
| US9204864B2 (en) | 2012-08-01 | 2015-12-08 | Magnolia Medical Technologies, Inc. | Fluid diversion mechanism for bodily-fluid sampling |
| ES2878047T3 (es) | 2012-10-11 | 2021-11-18 | Magnolia Medical Technologies Inc | Sistema para administrar un fluido a un paciente con contaminación reducida |
| DE102012022826B4 (de) * | 2012-11-22 | 2022-10-13 | Hubert Wöllenstein | Verfahren zur Herstellung eines gepoolten Thrombozytenkonzentrats |
| CA3136331C (fr) | 2012-11-30 | 2024-05-21 | Magnolia Medical Technologies, Inc. | Mecanisme de deviation de fluide par une seringue pour l'echantillonnage de liquide organique |
| US10772548B2 (en) | 2012-12-04 | 2020-09-15 | Magnolia Medical Technologies, Inc. | Sterile bodily-fluid collection device and methods |
| EP3305196B8 (fr) | 2012-12-04 | 2023-03-08 | Magnolia Medical Technologies, Inc. | Dispositif stérile de recueil de fluide corporel |
| US10159778B2 (en) | 2014-03-24 | 2018-12-25 | Fenwal, Inc. | Biological fluid filters having flexible walls and methods for making such filters |
| US9782707B2 (en) | 2014-03-24 | 2017-10-10 | Fenwal, Inc. | Biological fluid filters having flexible walls and methods for making such filters |
| US9968738B2 (en) | 2014-03-24 | 2018-05-15 | Fenwal, Inc. | Biological fluid filters with molded frame and methods for making such filters |
| US9796166B2 (en) | 2014-03-24 | 2017-10-24 | Fenwal, Inc. | Flexible biological fluid filters |
| US10376627B2 (en) | 2014-03-24 | 2019-08-13 | Fenwal, Inc. | Flexible biological fluid filters |
| US11135343B2 (en) | 2016-12-01 | 2021-10-05 | Fenwal, Inc. | Blood component pooling device, system and method |
| IL271054B2 (en) | 2017-06-09 | 2024-05-01 | Magnolia Medical Technologies Inc | Fluid control devices and methods of using the same |
| CN111212597B (zh) | 2017-09-12 | 2023-04-11 | 木兰医药技术股份有限公司 | 流体控制装置及其使用方法 |
| JP7553455B2 (ja) | 2019-02-08 | 2024-09-18 | マグノリア メディカル テクノロジーズ,インコーポレイテッド | 体液採取及び分配のための装置及び方法 |
| EP4717174A3 (fr) | 2019-12-11 | 2026-06-17 | Magnolia Medical Technologies, Inc. | Dispositifs de transfert de fluide avec dosage à base d'écoulement intégré |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2058577A5 (fr) * | 1969-09-17 | 1971-05-28 | Medicoplast Labor | |
| US4280497A (en) * | 1979-10-09 | 1981-07-28 | Cutter Laboratories, Inc. | Container for platelet storage |
| US4670013A (en) * | 1982-12-27 | 1987-06-02 | Miles Laboratories, Inc. | Container for blood and blood components |
| WO1989009025A1 (fr) * | 1988-03-31 | 1989-10-05 | Maria Hansby | Unite de collecte de sang et son emploi |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68902698C5 (de) * | 1988-06-23 | 2005-07-14 | Asahi Medical Co. Ltd. | Verfahren zur Trennung von Blut in Blutkomponenten und Einheit zur Trennung von Blutkomponenten. |
| US5100564A (en) * | 1990-11-06 | 1992-03-31 | Pall Corporation | Blood collection and processing system |
| CA2072378C (fr) * | 1991-11-21 | 2000-12-26 | Vlado Ivan Matkovich | Methode d'assemblage de plusieurs receptables contenant un fluide biologique |
| US5549834A (en) * | 1991-12-23 | 1996-08-27 | Baxter International Inc. | Systems and methods for reducing the number of leukocytes in cellular products like platelets harvested for therapeutic purposes |
| CA2083075A1 (fr) * | 1992-06-10 | 1993-12-11 | Vlado I. Matkovich | Systeme pour le traitement du materiau de la zone de transition |
-
1997
- 1997-12-19 EP EP97954595A patent/EP0949946A4/fr not_active Withdrawn
- 1997-12-19 AU AU59008/98A patent/AU736156B2/en not_active Ceased
- 1997-12-19 WO PCT/US1997/023558 patent/WO1998028057A1/fr not_active Ceased
- 1997-12-19 CA CA002271440A patent/CA2271440A1/fr not_active Abandoned
- 1997-12-19 JP JP52899698A patent/JP2001507353A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2058577A5 (fr) * | 1969-09-17 | 1971-05-28 | Medicoplast Labor | |
| US4280497A (en) * | 1979-10-09 | 1981-07-28 | Cutter Laboratories, Inc. | Container for platelet storage |
| US4670013A (en) * | 1982-12-27 | 1987-06-02 | Miles Laboratories, Inc. | Container for blood and blood components |
| WO1989009025A1 (fr) * | 1988-03-31 | 1989-10-05 | Maria Hansby | Unite de collecte de sang et son emploi |
Non-Patent Citations (1)
| Title |
|---|
| See also references of WO9828057A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001507353A (ja) | 2001-06-05 |
| CA2271440A1 (fr) | 1998-07-02 |
| AU736156B2 (en) | 2001-07-26 |
| WO1998028057A1 (fr) | 1998-07-02 |
| EP0949946A1 (fr) | 1999-10-20 |
| AU5900898A (en) | 1998-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU736156B2 (en) | Biological fluid processing | |
| EP0540732B1 (fr) | Systemes et procedes permettant d'eliminer les substances indesirees des cellules du sang | |
| US5089146A (en) | Pre-storage filtration of platelets | |
| US5364526A (en) | System for processing separate containers of biological fluid | |
| US5236716A (en) | Platelets concentrate with low white blood cells content | |
| US5738796A (en) | Method for separating components from a biological fluid | |
| EP0540734B1 (fr) | Systemes et procedes destines a eliminer des materiaux non desires de cellules sanguines | |
| US5472621A (en) | Method for treating transition zone material | |
| US5512187A (en) | Methods for processing red cell products for long term storage free of microorganisms | |
| CA2137797C (fr) | Systeme de traitement du materiel present dans une zone de transition | |
| US6358420B2 (en) | Blood collection method employing an air venting blood sample tube | |
| CA2143680A1 (fr) | Processus et appareil permettant de retirer les liquides indesires des produits sanguins traites | |
| EP0623045B1 (fr) | Methode de filtrage d'un fluide corporel mettant en uvre une poche de rincage | |
| WO2000007642A1 (fr) | Systeme de traitement de fluides biologiques | |
| JPH04236959A (ja) | 血液成分分離方法 | |
| JP2013203659A (ja) | 血液処理フィルタ及び血液回路 | |
| HK1126378B (en) | Prechargeable fluid filtration method and apparatus | |
| HK1126378A1 (en) | Prechargeable fluid filtration method and apparatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19990414 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT DE ES FR GB IT |
|
| RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7B 01D 21/26 A, 7B 01D 36/00 B, 7A 61M 1/00 B, 7A 61M 1/02 B |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20010103 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT DE ES FR GB IT |
|
| 17Q | First examination report despatched |
Effective date: 20030408 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20040806 |